Academic Jobs - Home of Higher Ed Logo

Pirbright-Led Study: East African Bat Coronavirus Enters Human Cells via Novel Pathway

Submit News
Navy officer checks sailor's temperature with thermometer.
Photo by Navy Medicine on Unsplash

Breakthrough Discovery: A New Pathway for Bat Coronaviruses

The recent study from The Pirbright Institute has sent ripples through the virology community by identifying a novel way certain bat coronaviruses can infiltrate human cells. Researchers discovered that Cardioderma cor coronavirus KY43, or CcCoV-KY43, sourced from heart-nosed bats in Kenya, binds to the human receptor CEACAM6—a carcinoembryonic antigen-related cell adhesion molecule 6 predominantly expressed in lung tissues. This finding challenges previous assumptions that alphacoronaviruses primarily rely on aminopeptidase N (APN) for entry, expanding our understanding of potential zoonotic threats.

Heart-nosed bats, ecologically vital insectivores found across eastern Africa from Sudan to Tanzania, harbor this virus in areas like coastal Kenya where human-bat interfaces are common, such as artisanal mines. While no human infections have been confirmed through serological testing of 368 samples from the Taveta region, the virus's ability to use a human receptor raises flags for proactive surveillance.

The Receptor Revelation: CEACAM6's Role Explained

CEACAM6, part of the carcinoembryonic antigen family, facilitates cell adhesion and is upregulated in certain cancers and inflammatory conditions. In this context, the virus's receptor-binding domain (RBD) engages CEACAM6's N-terminal IgV-like domain via three key loops, dominated by hydrophobic interactions like tryptophan at position 600 docking into leucine 129. Crystal structures (PDB: 9RCS for KY43-CEACAM6) confirm this precise fit, with binding affinity around 271 nM.

Unlike SARS-CoV-2's ACE2 or MERS-CoV's DPP4, this marks a first for alphacoronaviruses using CEACAM6 independently. Related Kenyan viruses CcCoV-2A and CcCoV-2B share 70-83% RBD identity and similar tropism, while Asian and Russian bat alphacoronaviruses show restricted nonhuman compatibility. Experiments using pseudotyped lentiviruses in HEK293T, Calu3 lung, and Caco2 intestinal cells, plus siRNA knockdowns, validated CEACAM6 dependency—no entry without it.

Crystal structure of CcCoV-KY43 RBD bound to human CEACAM6 receptor

European Leadership in Cutting-Edge Virology Research

UK institutions spearheaded this effort, exemplifying Europe's prowess in interdisciplinary virology. The Pirbright Institute, funded by BBSRC under UKRI, led pseudotyping and functional assays. University of Cambridge's Department of Pathology solved atomic structures and conducted binding studies. University of York's Hull York Medical School screened receptor libraries using their proprietary platform, pinpointing CEACAM6.

Imperial College London contributed expertise in infectious diseases. This collaboration highlights how European higher education fosters global partnerships, integrating computational phylogenetics, structural biology, and epidemiology. Professor Gavin J. Wright at York noted, "Our human receptor discovery platform identified a new coronavirus receptor, proving invaluable for emerging viruses." Such synergies position Europe as a hub for pandemic intelligence.

Innovative Methods: From Genes to Structures

A greedy algorithm selected 40 spike proteins from 2,714 alphacoronavirus sequences, capturing 53.4% phylogenetic diversity. Pseudotyped onto HIV-1 lentiviruses (verified by immunoblot), they were screened against libraries of APN (25 species), ACE2 (34), and 759 human ectodomains. CcCoV-KY43 excelled in Calu3/Caco2 entry, blocked by anti-CEACAM6 antibodies.

Bio-layer interferometry and isothermal titration calorimetry quantified affinities; mutagenesis (e.g., I63F in CEACAM) dissected specificity. Bayesian phylogenetics dated the most recent common ancestor to ~1833, suggesting multiple CEACAM6 acquisitions. No live virus needed—biosafe spike-only approach.

Blue face masks hanging from car rearview mirror.

Photo by Daisy D on Unsplash

  • Computational selection for maximal diversity
  • Pseudotype entry assays in human cell lines
  • Structural biology via X-ray crystallography
  • Serological surveillance in endemic areas

Geographic Spread and Host Tropism Insights

CcCoVs circulate in Kenyan bats, mapped by National Museums of Kenya. East African strains show broad tropism (primates, Yinpterochiroptera bats), while Eurasian ones are narrower. CEACAM6's lung expression (higher than ACE2/APN) suggests respiratory potential. Evolutionary models indicate zoonotic hotspots at human-bat interfaces.

For more on the virus's structure and binding, see the full Nature paper.

Implications for Pandemic Preparedness in Europe

This underscores the need for receptor-agnostic surveillance. Europe's PREDICT-like programs, bolstered by UKRI funding, can preempt spillovers. Pirbright's spike-only platform scales globally, aiding vaccine design targeting conserved RBD motifs. Dr Dalan Bailey emphasized, "Alphacoronaviruses might use a variety of receptors, urging broader screening."

Stakeholders: Policymakers fund bat monitoring; universities train virologists; pharma develops broad-spectrum antivirals. Case study: Post-SARS surveillance caught HKU1 using CEACAM1.

Expert Perspectives: Caution Amid Alarm

Science Media Centre experts praise the methodical approach but caution: low spillover evidence; cell entry ≠ replication/disease. Prof. Wendy Barclay (Imperial): "Important for receptor diversity awareness." Dr. Andrew Easton (Kent): "No panic; enhances preparedness." Balanced views stress investment over fear.

Read expert reactions at the Science Media Centre.

European Universities Driving Global Surveillance

Cambridge's structural insights, York's receptor tech exemplify higher ed's role. Collaborations with Kenyan partners via BBSRC-NRF build capacity. Timeline: Sampling 2010s; screening 2021-2025; publication 2026. Stats: Alphacoronaviruses underrepresented vs betacoronaviruses in surveillance (only 2/25 pseudotypes used known receptors).

Woman wearing a face mask and glasses

Photo by Vitaly Gariev on Unsplash

Heart-nosed bat in Kenyan habitat, natural reservoir for CcCoV-KY43

Future Directions: Vaccines, Antivirals, and Monitoring

Target RBD loops for pan-alphacoronavirus vaccines. Expand CEACAM6 screens for other families. Europe's Horizon Europe funds such work. Actionable: Boost bat sampling in EU migration flyways; integrate AI phylogenetics.

Explore Pirbright's full announcement here.

Why This Matters for European Higher Education

UK unis like Cambridge/York train next-gen researchers, securing biosecurity leadership. Interdisciplinary programs in structural virology, bioinformatics thrive. Impacts: Policy influence, industry spinouts, student opportunities in zoonoses.

Portrait of Sarah West
About the author

Sarah WestView author

Academic Jobs In House Author

Discussion

Sort by:

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

🦇What is CcCoV-KY43?

CcCoV-KY43 is an alphacoronavirus from heart-nosed bats in Kenya, capable of entering human cells via CEACAM6.

🔬How does the virus enter human cells?

Its spike protein's RBD binds CEACAM6's IgV domain using hydrophobic loops, confirmed by crystal structures.

Is there evidence of human infection?

Serological tests on 368 Kenyans showed no significant spillover; sporadic signals likely cross-reactive.

🏛️Which European universities were involved?

University of Cambridge (structures), University of York (receptor screening), Imperial College London.

🧪What methods were used?

Pseudotyped lentiviruses screened against receptor libraries; ITC, crystallography, phylogenetics.

🫁Why is CEACAM6 significant?

Highly expressed in lungs, enables respiratory tropism; novel for alphacoronaviruses.

⚠️What are the pandemic implications?

Broadens surveillance needs; aids vaccine design targeting RBD; no immediate threat.

📊How prevalent is the virus in bats?

Detected in Kenyan heart-nosed bats; mapped nationally; exact rates not quantified here.

🔮What next for research?

Enhanced East African surveillance, pan-coronavirus vaccines, receptor-agnostic platforms.

🎓Role of European higher ed?

Leads in tech like York's platform; trains experts; funds via UKRI for global health security.

🧬Any related viruses?

Kenyan CcCoV-2A/2B; Eurasian bat alphaCoVs use nonhuman CEACAM6 variants.